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Abstract
ADHD is associated with various cognitive deficits, including general performance decrements 
and specific impairments, for instance in temporal processing. However, time preparation under 
uncertain conditions has been under-investigated in this population. We aimed at filling this gap. 
We administered a variable foreperiod paradigm to children with ADHD before and after a one-
month treatment with modified-release methylphenidate. Age-matched ADHD children with no 
treatment and healthy children were also tested as control groups with the same time-schedule. 
Children with ADHD had general performance deficits (longer and more variable response times), 
which disappeared in the experimental group after pharmacological intervention. Moreover, ADHD 
children showed a marked dependency on sequential foreperiod effects (i.e., slower responses for 
longer preceding foreperiods), especially at short current foreperiods, which were not modulated 
by the pharmacological treatment. In conclusion, the present findings show that methylphenidate 
enhances general motor processes rather than more specific time preparation processes, some of 
which appear deviant in ADHD.
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1. Introduction
Attention-deficit/hyperactivity disorder (ADHD) is one of the most prevalent 
developmental disorders characterized by symptoms of inattention, hyperactiv-
ity and impulsivity (American Psychiatric Association, 2013). ADHD is also as-
sociated with neurocognitive impairments (e.g., Vallesi et al., 2013a; see Sergeant 
et al., 2002, for a review). Some studies highlight basic information processing 
problems in ADHD as shown by response slowing and increased response time 
(RT) variability (Johnson et al., 2008; Klein et al., 2006; Kuntsi et al., 2003; Scheres 
et al., 2003).
More specific deficits include problems in inhibitory control (Kramer et al., 
2001) and spatial attention orienting, which allows attention to be allocated to 
and manipulated within certain regions of visual space, independently of wheth-
er attention orienting is triggered strategically through a symbolic central cue 
(McDonald et al., 1999) or automatically through a changing peripheral cue (Per-
chet et al., 2001). Therefore, it seems likely that ADHD may affect the effective-
ness of visuo-motor preparation, including the ability to use warning signals to 
effectively orient attention not only in space but also in time.
It is also known that ADHD children have problems with time processing in 
general, which may result in time underestimation, suggesting that they have 
an abnormally fast internal clock with respect to controls (Luman et al., 2009; 
Toplak et al., 2006), although these deficits may not be observed in musical con-
texts (Carrer, 2015). Time processing deficits in ADHD may be related to prob-
lems with preparation and planning and with hyperactive and impulsive behavior 
(Oosterlaan et al., 2005; Sergeant et al., 2002). A recent review shows that ADHD 
patients are consistently impaired in three main time-processing domains: motor 
timing, perceptual timing and temporal foresight, with the deficits being associat-
ed with dysfunctions in the fronto-striato-cerebellar and fronto-parietal networks 
that mediate time-processing (Noreika et al., 2013).
An underinvestigated aspect of the general time-processing framework in 
ADHD is implicit time preparation. This ability has been traditionally studied 
by manipulating the waiting time between a warning stimulus and a target, the 
so-called foreperiod (FP; Woodrow, 1914). A small number of previous studies 
specifically investigating temporal preparation in ADHD used an implicit time 
preparation design with a fixed preparatory interval (foreperiod) administration 
(Hurks et al., 2005; Leth-Steensen et al., 2000). One of these studies showed that 
ADHD children have problems preparing a response with relatively long (1000 
ms) but not with short (100 ms) fixed FPs (Hurks et al., 2005).
Preparatory strategies, however, may change dramatically as a function of how 
the FP is manipulated (Niemi & Näätänen, 1981). The variable FP administration, 
especially when FPs of different length are administered randomly and equiprob-
ably, has been shown to give rise to both a current trial FP effect (i.e., shorter RTs for 
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longer current FPs) and sequential effects (i.e., longer RTs for longer previous FPs). 
Thus, it remains to be investigated whether ADHD children have problems with 
temporal preparation in a variable FP context, and in particular with processes 
linked to sequential effects, which are consistently believed to be automatic (Los 
& Van den Heuvel, 2001; Los et al., 2014; Vallesi & Shallice, 2007) and probably 
motoric (Vallesi et al., 2007a) in nature, or with dissociable mechanisms underly-
ing the variable FP effect. The latter has been shown to be related, anatomically, 
to the functionality of the lateral prefrontal cortex (Triviño et al., 2010; Vallesi & 
Shallice, 2007; Vallesi et al., 2007a, b) and, cognitively, with a more strategic, con-
trolled process which monitors the changing conditional probability of stimulus 
occurrence in time (e.g., Niemi & Näätänen, 1981; Vallesi & Shallice, 2007; Vallesi 
et al., 2013b). Indeed, the two effects have been dissociated as a function of task-
demands, with dual-task manipulations affecting more the variable FP effect than 
sequential effects (Vallesi et al., 2014), as well as in terms of their developmental 
trajectories, with sequential effects emerging earlier than the variable FP effect 
(Vallesi & Shallice, 2007).
From a functional-anatomical point of view, ADHD is associated with dysfunc-
tion and anatomical abnormalities in the fronto-striatal circuitry (Cubillo et al., 
2012; Curatolo et al., 2009), which, especially in the right hemisphere, correlates 
with response inhibition deficits in ADHD (Curatolo et al., 2010). A catechol-
amine dysfunction is also reported in ADHD children (Curatolo et al., 2009; Spen-
cer et al., 2005).
Methylphenidate (MPH) is an effective and well-established treatment for 
ADHD that has been shown to modulate dopamine and noradrenaline signaling 
by blocking the respective monoamine transporters, and increasing extracellular 
dopamine levels in the striatum, with improvements in motivation and reward 
(Taylor et al., 2004; Banaschewski et al., 2006). It also increases binding of dopa-
mine and the potentiation of dopamine neurotransmission, by diminishing the 
availability of D2 and D3 receptors, thus reducing inattention and impulsivity. 
During cognitive tasks MPH increases cerebral blood flow in the prefrontal cor-
tex in ADHD patients (Schweitzer et al., 2004). The MPH efficacy and effective-
ness in reducing inattentiveness and impulsiveness is confirmed by numerous 
placebo-controlled randomized control trials, with an effect size on hyperactivity 
symptoms in the range 0.8–1.1, and a response rate of at least 70% (Banaschewski 
et al., 2006; NICE, 2008).
New-generation formulations of MPH have been developed recently, which 
have a long-acting profile, since they combine both immediate-release (IR) and 
modified-release (MR) mechanisms (González et al., 2002; Pelham et al., 2001), 
therefore eliminating the requirement for extra daily doses (Pelham et al., 2011). 
A recent quantitative review (Coghill et al., 2014), mostly including studies using 
single dose MPH-IR, demonstrated that MPH-IR also improves various cognitive 
processes in ADHD, including executive and non-executive aspects of working 
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memory, response inhibition, reaction time (RT) and RT variability. The aim of 
designing a system-controlled release of a drug is to obtain a formulation that re-
leases the active substance at a rate necessary to achieve and maintain a constant 
concentration in the blood. Little is known about the effects of new-generation 
formulations of MPH-MR on cognition.
A goal of the present work was to fill the gap present in the literature regarding 
the relationship between ADHD and implicit temporal preparation in a variable 
FP context, and to gain insight into the cognitive effects of MPH-MR in the time 
preparation domain. In particular, we administered a variable FP task to children 
with ADHD before and after a one-month pharmacological intervention with 
MPH-MR. We also recruited and tested with the same modalities another group of 
age- and sex-matched ADHD children with no pharmacological intervention and 
a group of healthy control children.
Generally, we expected to replicate the classical finding of slower and more 
variable absolute RTs in ADHD as obtained with a time preparation RT task. 
A more specific prediction would be that ADHD children are only influenced by 
automatic preparation processes, as reflected by sequential FP effects, if they are 
less able to reach an optimal preparation level with longer FPs in a variable FP 
context. This hypothesized pattern would be similar to what happens with young-
er (4–5 years old) children (Vallesi & Shallice, 2007). The latter prediction also 
derives from the literature that highlights ADHD-related abnormalities in brain 
regions (e.g., Casey et al., 1997), as these overlap with the (right) dorsolateral pre-
frontal cortex recruited for the implementation of the preparatory strategies in-
volved in this paradigm (e.g., Triviño et al., 2010; Vallesi et al., 2007a). In addition, 
the observation that ADHD children show problems in attentional orienting, as 
evidenced by using visuo-spatial attention tasks (McDonald et al., 1999; Perchet 
et al., 2001), also provides support for this predictions. Alternatively, it could be 
that the already reported deficits in attentional orienting are limited to the visuo-
spatial domain and do not generalize to (implicit) temporal processing.
From a pharmacological point of view, we generally expected to replicate previ-
ous findings that MPH intervention would improve performance by accelerating 
RTs and making them less variable (Coghill et al., 2014; cf. Johnson et al., 2008). 
More specifically, we wanted to understand whether the pharmacological therapy 
would improve strategic time preparation processes in ADHD by increasing the 
variable FP effect and/or by making it less susceptible to automatic sequential 
effects.
2. Method
2.1. Participants
Three samples of children were recruited for the present study (see Table 1 for details). The three 
samples were composed of: 14 children with ADHD who underwent pharmacological intervention 
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with methylphenidate therapy; 17 control children with ADHD who did not undergo any pharma-
cological intervention; and 14 healthy control children. No significant age difference emerged across 
the groups (for all, p > 0.05). All patients with ADHD were consecutive referrals from the Child 
Psychiatry Unit of “Tor Vergata” University, Rome. For all of them the ADHD diagnosis was made in 
accordance with DSM-IV-TR criteria (American Psychiatry Association, 2000). The Conners’ Parents 
Rating Scale (CPRS), the Conners’ Teachers Rating Scale (CTRS; Conners, 2007), when possible, and 
the ADHD Rating Scale-IV were used to support the diagnosis and to define the ADHD subtype. To 
ensure a homogenous sample, the Kiddie Schedule of Affective Disorders (Kaufman et al., 2004) 
screening interviews were used to investigate the presence of ADHD during childhood and to ex-
clude other psychiatric comorbidities. Inclusion criteria were: diagnosis of ADHD combined-type, 
no mental retardation, no brain trauma, no neurological diseases or physical impairment, no co-
morbid mental disorders (investigated using K-SADS), except for possible learning disabilities (LD). 
ADHD children were evaluated for learning abilities with the “Battery for the Diagnosis of Develop-
mental Dyslexia” (Sartori, Job, & Tressoldi, 1995), and the “Battery for the Diagnosis of Developmen-
tal Dyscalculia” (Biancardi & Nicoletti, 2004). Children who received a standardized score below the 
cut-off for their school grade were given a diagnosis of dyslexia and/or dyscalculia.
Eight participants with ADHD additionally suffered from mixed LD. None of the ADHD diag-
nosed children had a previous history of stimulant treatment. All the pharmacological treatments 
were indicated by a child psychiatrist. The non-pharmacological ADHD group included children 
whose parents refused a pharmacological treatment or children for whom the pharmacological 
treatment was not an option due to heart problems. For patients with ADHD who started the phar-
macological treatment with modified release MPH at the first visit, health history (including vital 
signs, height, and weight), demographic data and neurological history were checked. They started 
the pharmacological treatment at an initial dose of 10 mg/day. In the subsequent two visits the 
neurological assessment was performed, including vital signs, weight, and height, questioning for 
the presence of any adverse effects, or concurrent treatments and verifying compliance with the 
treatment. After one month of pharmacological treatment the effective dose ranged from 0.3 mg 
to 1.5 mg/kg/day taken as a single dose in the morning. In all ADHD patients the Conners’ scale for 
parents and teachers was completed before starting drug treatment and one month after to verify 
the improvement of ADHD symptoms.
Table 1.
Clinical and demographic characteristics of our sample of participants at first evaluation.
ADHD in treatment  
with MPH
ADHD without MPH 
treatment
Healthy  
subjects
N 14 17 14
Sex M/F 13/1 14/3 9/5
Mean age in years (range) 10.8 (7–15) 10 (6–15) 11 (6–14)
Mean T score Conners’ Parents (mean ± SD)
 Inattention 72 ± 8.2 70 ± 9.7 50 ± 4.5
 Hyperactivity 78 ± 9.3 73 ± 8.7 46 ± 4.3
 ADHD index 76 ± 8.5 73 ± 9.3 56 ± 4
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Healthy controls were recruited from local schools in Rome. None of them had a history of 
neurological/psychiatric disease or LD documented by interviewing the children’s parents. A po-
tential diagnosis of ADHD, according to the DSM-IV-TR criteria, was excluded in all control partici-
pants using the ADHD Rating Scale-IV and CPRS with parents. At the time of testing, no participant 
was taking medications known to affect the central nervous system. All participants had normal or 
corrected-to-normal vision. We assume that there were no marked socio-demographic differences 
between the patients and controls given that all subjects attended public schools and lived in the 
same area of Rome (although this was not explicitly tested). All subjects enrolled in the study were 
tested twice a month apart in the late morning.
The study procedure was approved by the Child Psychiatry and Neurology Institute Ethical Com-
mittee of Tor Vergata University, Rome and was in accordance with the 1964 Helsinki declaration 
and its later amendments or comparable ethical standards. Before testing each child, a parent/legal 
guardian signed a written informed consent form.
2.2. Materials
The experiment was conducted on a Toshiba Satellite 1410-604 portable notebook. Responses 
were  collected from the notebook’s keyboard. Participants’ sight was kept at a distance of about 
50–60 cm from the center of the computer screen, with their dominant hand index finger resting on 
the spacebar. Auditory Warning Stimulus (WS) was presented at a comfortable level.
All visual stimuli were presented against a black background. A centrally presented cross, con-
sisting of two yellow crossed bars 1.0 × 0.5 cm in size, served as the fixation stimulus (FS). The WS 
was a 1500 Hz pure tone, presented for 50 ms. The Imperative Stimulus (IS) was a downward point-
ing white arrow 2 cm long that consisted of a 1.5 × 1 cm bar attached to a 0.5 cm arrowhead with 
a maximum width of 2 cm (note that the stimuli are very similar to those used previously by Los & 
Van Den Heuvel, 2001, and by Vallesi & Shallice, 2007). The FP interval between the warning and 
the IS could last 1, 2 or 3 s. Each session consisted of 120 trials, where the three FPs were randomly 
intermixed.
Task. A trial started with the presentation of the FS together with the WS. The onset of the WS 
marked the beginning of the Foreperiod (FP). When the FP expired, the FS disappeared, and the IS 
appeared at the center of the screen. Participants were instructed to respond as fast as possible only 
to the IS by pressing the spacebar. The IS disappeared upon response key press. After a blank interval 
of 2000 ms, a new trial started.
2.3. Design and Procedure
The within-subject independent variables included FP (1, 2 or 3 s), session (two sessions with about 
a one-month interval). For the experimental ADHD group, the second session was administered 
after the pharmacological treatment with MPH-MR.
Three practice trials were given before the real test, in order to briefly familiarize participants 
with the procedure and allow the experimenter to check whether the instructions were clear. After 
the first 60 trials of the test phase, participants received a rest break during which they were en-
couraged to relax as needed. The break ended when the participants pressed the spacebar and the 
second and last block of trials started.
2.4. Data Analysis
Trials on which the Reaction Time (RT) was beyond the 200–2000 ms range were discarded from 
further analyses. Mean RTs and standard deviations were analyzed separately though ANOVAs with 
group (ADHD with pharmacological treatment between sessions, ADHD without treatment, control 
children), as the between subject factor, and session (first, second), previous FP (1, 2, 3 s) and cur-
rent FP (1, 2, 3 s), as the within-subject factors. For the significant effects, a post-hoc Tukey tests were 
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performed in order to further investigate more specific paired comparisons. Planned comparisons 
were used to investigate more complex comparisons. Early responses (spacebar press during the FP) 
were also collected and analyzed in a separate ANOVA.
3. Results
3.1. Reaction Times (RTs)
Mean RTs are plotted in Fig.  1. There was a significant group main effect [F(2, 
42) = 4.2, p = 0.022,  ηp2 = 0.17]. Planned comparisons showed that the ADHD 
group with no intervention had (across the two sessions) longer RTs than both 
of the other two groups (p < 0.001). Also the ADHD group with pharmacologi-
cal intervention had longer RTs than the healthy control group (p < 0.001). The 
main effects of the current FP [F(2, 42) = 59.56, p < 0.0001,  ηp2 = 0.58] and pre-
ceding FP [F(2, 42) = 61.56, p < 0.0001,  ηp2 = 0.59] were also significant. These 
effects were qualified by a preceding by current FP interaction [F(4, 168) = 16.8, 
p < 0.0001,  ηp2 = 0.28], which showed the classical asymmetric sequential FP ef-
fects (strongest for short FPs). A current FP by group interaction [F(4, 84) = 3.77, 
p < 0.007,  ηp2 = 0.15] showed that, contrary to the original hypothesis, the two 
ADHD groups had a more pronounced variable FP effect than controls, as also 
demonstrated by planned comparisons contrasting differential RTs for shortest 
and longest current FPs in each pair of groups (ADHD with intervention vs. con-
trols, p = 0.05; ADHD without intervention vs. controls, p = 0.004; the two ADHD 
groups, p = 0.34). This two-way interaction however was better represented by a 
three-way interaction between preceding FP, current FP and group [F(8, 168) = 
3.59, p = 0.0007,  ηp2 = 0.146]. This interaction was mainly due to RTs for short 
FPs being more modulated by the preceding FP length for the two ADHD groups 
than for the healthy control group. To corroborate this hypothesis, planned com-
parisons were run with RT differences between the shortest and longest preceding 
FPs during the current short FP for each pair of groups. There was a significant dif-
ference between ADHD children with pharmacological intervention and healthy 
controls (p = 0.03) and ADHD children without intervention and healthy controls 
(p = 0.003), but not between the two ADHD groups (p = 0.43). No such difference 
was observed for current long FPs in any pair of groups (for all, p > 0.21).
Another way to break the three-way interaction down was to look at the interac-
tion between group and current FP at each preceding FP. No interaction between 
group and current FP was observed at the shortest preceding FP (p = 0.835). This 
interaction instead emerged for both the middle preceding FP (p = 0.0007) and 
the longest one (p = 0.0029). This analysis confirmed that the current FP effect of 
the two ADHD groups was more pronounced than that of controls only at longer 
preceding FPs.
A final way to gain insight into the preceding FP by current FP by group interac-
tion is to unpack it by group. When we analyzed the data in this way, we found that 
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Figure  1. Mean RTs in ms (and 95% confidence intervals) according to the three experimental 
groups, session, current foreperiod (FP) and preceding FP. ‘MPH-MR ADHD’ denotes the ADHD 
group with modified-release methylphenidate treatment; ‘Control ADHD’ indicates the control 
group of children with ADHD with no pharmacological treatment. This figure is published in colour 
in the online version.
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all groups showed a main effect of current FP (for all, p < 0.00015) and preceding 
FP (for all, p < 0.00003), demonstrating that all groups showed reliable variable 
FP effects and sequential effects. However, only the two ADHD groups showed a 
significant interaction between these two factors, that is, the asymmetric sequen-
tial effects (for both, p < 0.0002), while the control group did not show this in-
teraction (p = 0.52), demonstrating that sequential effects were present in this 
group (as shown by a preceding FP main effect) but symmetrically spread across 
the three current FPs. This finding replicates previously reported results (Vallesi 
& Shallice, 2007), although with older children than those tested in the original 
study, and confirms that it is possible to dissociate the presence of the variable FP 
effect from the shape (symmetric vs. asymmetric) of the sequential effects (cf. Los 
& Van den Heuvel, 2001).
There was also a significant session by group interaction [F(2, 42) = 4.19, 
p = 0.022, ηp2 = 0.17]. This interaction seemed to be due to the fact that, while 
the ADHD group with pharmacological intervention decreased their RTs from 
the first session to the second one (p = 0.024), the other two groups numerically 
increased their RTs from one session to the next one (although this was not sta-
tistically significant, for both p > 0.15). To back up this impression statistically, 
planned comparisons on RT differences between session 1 and 2 were run for 
each pair of samples. This analysis showed that ADHD children with pharmaco-
logical intervention were significantly different from healthy controls (p = 0.029) 
and ADHD children with no intervention (p = 0.009), while the other two groups 
did not show any difference (p = 0.72). If we look at these data from a different 
angle, in the first session RTs were longer for the ADHD group with no subsequent 
intervention than for healthy controls (p < 0.033) and tended to be higher for 
the ADHD group with subsequent treatment than for healthy controls (p = 0.09), 
with no difference between the two ADHD samples (p = 0.331). In the second 
session, however, the ADHD children after pharmacological intervention did not 
differ from healthy controls (p = 0.902) and outperformed ADHD children with 
no intervention (p = 0.017), while in the latter group the disadvantage with re-
spect to the control group was maintained (p = 0.012). No other effect emerged 
as significant.
3.2. Standard Deviation
Standard Deviations (SD) are displayed in Fig.  2. There was a significant group 
main effect [F(2, 42) = 3.82, p = 0.0299, ηp2 = 0.15]. Planned comparisons showed 
that the ADHD group with no intervention had larger SDs (collapsing the two ses-
sions) than the other two groups (p < 0.001). Moreover, the ADHD group with 
treatment had larger SDs than healthy controls (p < 0.001). There were also pre-
ceding FP [F(2, 84) = 10.038, p = 0.0001, ηp22 = 0.19] and current FP [F(2, 84) = 
13.72, p < 0.0001, ηp2 = 0.25] main effects. Importantly there was a significant 
by group interaction [F(2, 42) = 4.06, p = 0.0244, ηp2 = 0.16]. This interaction 
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Figure  2. Standard deviation of response times (RTs) in ms (and 95% confidence intervals) 
according to the three experimental groups, session, current foreperiod (FP) and preceding FP. See 
Fig. 1 for further details. This figure is published in colour in the online version.
 A. Vallesi et al. / Timing & Time Perception 4 (2016) 207–222 217
seemed to be due to the fact that while the ADHD children with pharmacologi-
cal treatment tended to reduce their SDs from the first session to the second one 
(p = 0.059), the other two groups numerically increased their SDs from session 
1 to session 2 (although this effect did not reach statistical significance, for both 
p > 0.09). To corroborate this impression statistically, planned comparisons on 
SD differences between session 1 and 2 were run for each pair of samples. This 
analysis showed that the between-session SD difference in the ADHD children 
with pharmacological intervention was significantly different (i.e., higher) than 
the difference in healthy controls (p = 0.013) and ADHD children with no in-
tervention (p = 0.022), while these two groups did not differ from each other 
(p = 0.73). To put it differently, while in the first baseline session SDs were higher 
for both ADHD groups than for healthy controls (for both, p < 0.033), with no 
difference between each other (p = 0.57), in the second session, ADHD children 
after treatment reached the level of healthy controls (p = 0.99) and outperformed 
ADHD children with no intervention (p = 0.032), while the latter group showed 
larger SDs than the healthy controls (p = 0.031) as in the first session. No other 
effects emerged as significant.
3.3. Early Responses (during FP and Soon after IS) and Slow Responses
Anticipation responses during the FP and before the target onset occurred on 8% 
of the trials and this percentage did not differ significantly across the three groups 
(one-way ANOVA, p = 0.36). Early responses after target onset (RT < 200 ms) were 
rare (1.77% of total responses) and did not differ across groups (one-way ANOVA, 
p = 0.33). Delayed (RT > 2000 ms) and null responses (2.27% of total responses) 
also did not differ across groups (1-way ANOVA, p = 0.53).
4. Discussion
This is the first study in which implicit temporal preparation was studied in ADHD 
with a variable FP paradigm as well as the first to assess the cognitive effects of 
MPH-MR in time preparation. Our results showed that children with ADHD had 
general performance deficits such as longer and more variable RTs with respect 
to a control group of age-matched controls. Notably, general RT slowness and 
variability significantly diminished in the experimental group after MPH-MR 
pharmacological treatment. Our findings confirmed the main conclusions of a 
recent quantitative review (Coghill et al., 2014), which demonstrated that MPH-
IR (mostly given as a single dose) improves various basic cognitive performance 
measures in ADHD, including RT speed and (reduced) variability (also see Kuntsi 
et al., 2003; Scheres et al., 2003; but see Johnson et al., 2008, for more specific 
effects of MPH therapy on indices of executive functioning), and extends these 
results to the continuous use of MPH-MR for one month.
The present study was also specifically designed to test how ADHD children 
implement temporal preparation by using a variable FP paradigm and how their 
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performance on this task may change as a function of MPH-MR pharmacological 
treatment. This paradigm allows the dissociation of the automatic and controlled 
processes involved in temporal preparation (e.g., Steinborn & Langner, 2011; 
Vallesi & Shallice, 2007; Vallesi et al., 2014). Specific ADHD-related time prepa-
ration deficits included pronounced sequential FP effects at current short FPs, 
which suggests a higher susceptibility to automatic time-preparation processes 
(e.g., Los et al., 2014; Vallesi & Shallice, 2007). This pattern of results did not im-
prove with pharmacological treatment, suggesting that the MPH-MR effect does 
not specifically influence automatic time preparation processes.
Surprisingly, ADHD was not associated with a reduction of the variable FP ef-
fect, which according to some studies reflects more strategic time-preparation 
processes which include monitoring changing conditional probabilities in time 
by the lateral prefrontal cortex (e.g., Stuss et al., 2005; Vallesi et al., 2007a, b). On 
the contrary, the FP effect was exaggerated in the two ADHD groups as compared 
to controls, as shown by a significant current FP by group interaction. This may 
suggest that ADHD does not disrupt controlled monitoring processes in time 
preparation. There is instead the impression that these processes might even be 
enhanced in ADHD. However, it is possible that the variable FP effect, which is 
usually seen as a measure of controlled preparatory processes, may have been spu-
riously enhanced by a high influence of previous FP length at the shortest FPs, 
that is, by the presence of exaggerated sequential effects for the shortest current 
FPs. A follow-up Pearson’s correlation analysis indeed showed that the latter could 
be the case, as the FP effect (calculated as the RT difference between the short-
est and longest current FPs) and sequential effects on shortest FPs (calculated 
as the RT difference between the longest and shortest preceding FPs during the 
shortest current FPs) were positively correlated (r = 0.37, p = 0.012), when the 
three groups and the two sessions were collapsed together to maximize statistical 
power (no significant effect emerged instead when the correlations were comput-
ed separately for each group). An alternative way to understand how the sequen-
tial effects might influence the current FP effect would be to look at the current 
FP effect at each previous FP. When the data were analyzed in this way, the FP 
effect was comparable across groups at the shortest previous FP, while group dif-
ferences emerged at the middle and longest previous FPs, thus confirming that, 
in the present study, the estimated magnitude of the variable FP effect in ADHD 
children was probably confounded by the presence of exaggerated asymmetric 
sequential effects.
The limitations of the present study are the relatively small clinical sample of 
patients that does not allow generalization to the whole ADHD population, and 
the lack of a placebo control group with ADHD, which could have controlled for 
pharmacologically independent effects of treatment. Ethical considerations how-
ever prevented us from recruiting such a control group. Future studies should try 
to overcome this limit by recruiting different groups of ADHD children who may 
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receive treatment at different time schedules, or by comparing the effect of differ-
ent medication types in different ADHD groups.
In conclusion, this first investigation on the effect of MPH-MR on time prepara-
tion showed that ADHD is associated with worse performance in terms of absolute 
RTs and their variability. These deficits can be improved with MPH-MR pharmaco-
logical treatment. More ADHD-specific effects in implicit temporal preparation, 
such as exaggerated sequential effects with short preparatory intervals, are more 
resistant to MPH-MR intervention in ADHD, suggesting that this pharmacological 
therapy exerts its influence on general motor processing rather than on the more 
specific cognitive abilities involved in implicit time preparation.
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